Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1976 Aug 14;2(6032):394–396. doi: 10.1136/bmj.2.6032.394

Treatment of diabetic coma with small intravenous insulin boluses.

N Clumeck, A De Troyer, R Naeije, G Somers, L Smekens, E O Balasse
PMCID: PMC1687513  PMID: 947442

Abstract

The clinical efficacy of small intravenous boluses of insulin in treating diabetic decompensation was tested in 23 patients presenting in either a ketoacidotic or a nonketotic diabetic coma. In addition to the usual ionic and fluid replacement, the patients received hourly intravenous injections of insulin 5 IU. This dose lowered blood glucose levels in all but two patients. In the patients who responded the percentage decrease in glycaemia was similar whatever the initial glucose concentration and averaged (+/-SE of mean) 50+/-3% in five hours. Close monitoring of insulin and glucose concentrations after intravenous insulin in three patients showed that despite the short half life of insulin the effect of the intravenous bolus lasted for about 60 minutes. The overall clinical effectiveness of this type of treatment is comparable to that of the other low-dose regimens. Owing to its simplicity, this technique of insulin administration seems most suitable for the routine treatment of diabetic coma.

Full text

PDF
394

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alberti K. G. Letter: Intravenous insulin boluses in treatment of diabetic coma. Lancet. 1975 Sep 20;2(7934):547–548. doi: 10.1016/s0140-6736(75)90914-9. [DOI] [PubMed] [Google Scholar]
  2. Clumeck N., Detroyer A., Naeije R., Ectors M., Balasse E. O. Letter: small intravenous insulin boluses in the treatment of diabetic coma. Lancet. 1975 Aug 30;2(7931):416–416. doi: 10.1016/s0140-6736(75)92938-4. [DOI] [PubMed] [Google Scholar]
  3. Herbert V., Lau K. S., Gottlieb C. W., Bleicher S. J. Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab. 1965 Oct;25(10):1375–1384. doi: 10.1210/jcem-25-10-1375. [DOI] [PubMed] [Google Scholar]
  4. Kraegen E. W., Lazarus L., Meler H., Campbell L., Chia Y. O. Carrier solutions for low-level intravenous insulin infusion. Br Med J. 1975 Aug 23;3(5981):464–466. doi: 10.1136/bmj.3.5981.464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Page M. M., Alberti K. G., Greenwood R., Gumaa K. A., Hockaday T. D., Lowy C., Nabarro J. D., Pyke D. A., Sönksen P. H., Watkins P. J. Treatment of diabetic coma with continuous low-dose infusion of insulin. Br Med J. 1974 Jun 29;2(5921):687–690. doi: 10.1136/bmj.2.5921.687. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Semple P. F., White C., Manderson W. G. Continuous intravenous infusion of small doses of insulin in treatment of diabetic ketoacidosis. Br Med J. 1974 Jun 29;2(5921):694–698. doi: 10.1136/bmj.2.5921.694. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Soler N. G., FitzGerald M. G., Wright A. D., Malins J. M. Comparative study of different insulin regimens in management of diabetic ketoacidosis. Lancet. 1975 Dec 20;2(7947):1221–1224. doi: 10.1016/s0140-6736(75)92068-1. [DOI] [PubMed] [Google Scholar]
  8. Sönksen P. H., Srivastava M. C., Tompkins C. V., Nabarro J. D. Growth-hormone and cortisol responses to insulin infusion in patients with diabetes mellitus. Lancet. 1972 Jul 22;2(7769):155–159. doi: 10.1016/s0140-6736(72)91328-1. [DOI] [PubMed] [Google Scholar]
  9. Turner R. C., Grayburn J. A., Newman G. B., Nabarro J. D. Measurement of the insulin delivery rate in man. J Clin Endocrinol Metab. 1971 Aug;33(2):279–286. doi: 10.1210/jcem-33-2-279. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES